제약기업의 제휴 성과에 영향을 미치는 요인에 관한 연구 -제휴 불확실성, 포트폴리오 특성 및 수용 역량을 중심으로- = The study on factors affecting strategic alliance performance for pharmaceutical companies; The role of alliance uncertainty, alliance portfolios characteristics and absorptive capacity

다국어 초록 (Multilingual Abstract)

Recently, strategic alliance has become important for improving outcomes in high technology industries. This study tried to address the influence of alliance uncertainty, portfolio characteristics and absorptive capacity on strategic alliance performance in pharmaceutical industry. Prior researches also investigated strategic alliance but they were restricted to limited cases and subjects, conceptual framework and exploratory design.
From thorough literature review, more comprehensive research model and measurements than previous works were established. Based on alliances samples formed by pharmaceutical firms from 2003 to 2010, this study suggested a significant link between alliance uncertainty, portfolio characteristics, absorptive capacity and alliance performance in pharmaceutical business. It was also able to reveal the most powerful explanatory factor toward alliance outcome and propose favorable types of strategic networks to practitioners from the findings. From insights of this study, further study using complementary primary data incorporating managerial features in alliance could be a great step forward. Additional research based on more integrated and balanced measurements for qualitative aspects like alliance maintenance, optimization, integration, trust and coordination to assess managing issue after deal execution can also provide us meaningful contributions. By doing that, it is expected to draw more compelling factors to explain alliance dynamics for both academic and practical views.

참고문헌 (Reference)

1 심상만, "제약기업의 R&D 네트워크 활용전략" LG경제연구원 2000

2 고유상, "세계바이오산업의 M&A 동향" 삼성경제연구소 2007

3 여경철, "국제전략적제휴 참여기업들의 생산성 향상에 관한 연구" 한국생산성학회 17 (17): 103-120, 2003

4 정성민, "국내 제약회사의 효율성 및 생산성 분석" 한국생산성학회 25 (25): 239-265, 2011

5 김성아, "국내 제약회사의 생산성변화 분석: 2001년-2005년" 한국생산성학회 21 (21): 77-96, 2007

6 "http://www.thomson-pharma.com"

7 "http://mba.tuck.dartmouth.edu/pages/faculty/ken.french/data_library.html"

8 Adner, Ron, "What is not a real option: considering boundaries for the application of real options to business strategy" 29 (29): 74-85, 2004

9 "Trends in Pharmaceutical Portfolio Management"

10 "The pharmaceutical industry"

11 George, Gerard, "The effects of alliance portfolio characteristics and absorptive capacity on performance: A study of biotechnology firm" 12 (12): 205-226, 2001

12 Oxley, Joanne E., "The Scope and Governance of International R&D Alliances" 25 : 723-749, 2004

13 Rothaermel, Frank T., "Technological Discontinuities and Interfirm Cooperation: What Determines a Startup’s Attractiveness as Alliance Partner?" 49 (49): 388-397, 2002

14 Grindley, June N, "Success rates for strategic alliances - are they good enough?" 3 (3): 145-146, 1998

15 McCutchen, William W., "Strategic alliance termination and performance: The role of task complexity, nationality and experience" 18 (18): 191-202, 2008

16 Eisenhardt, K. M., "Resource-based view of strategic alliance formation: strategic and social effects in entrepreneurial firms" 7 (7): 136-150, 1996

17 Pieters, Michiel, "Mind the gap, Balancing alliance network and technology portfolios during periods of technological uncertainty" (26491) : 2009

18 "Mergers, acquisitions and licensing to continue to drive industry growth"

19 Kim, Yongtae, "Market uncertainty and disclosure of internal control deficiencies under the Sarbanes-Oxley Act" 28 : 419-445, 2009

20 Spender, John-Christopher, "Making knowledge the basis of a dynamic theory of the firm" 17 : 45-62, 1996

21 "Licensing strategies"

22 Muthusamy, Senthil K., "Learning and Knowledge Transfer in Strategic Alliances: A Social Exchange View" 26 (26): 415-441, 2005

23 Dussauge, Pierre, "Learning From Competing Partners: Outcomes and Durations of Scale and Link Alliances in Europe" 21 : 99-126, 2000

24 Gopalakrishnan, Shanthi, "Keeping Financially Afloat: The Influence of Resources and Social Capital on Financial Capital Acquisition by Small Biotechnology Firms from Large Pharmaceutical Firms at Alliance Formation" 2114-2223, 2006

25 Kogut, Bruce, "Joint ventures and the option to expand and acquire" 37 (37): 19-33, 1991

26 Schmid, Esther F., "Is pharmaceutical R&D just a game of chance or can strategy make a difference?" 9 (9): 18-26, 2004

27 Folta, T. B., "Governance and uncertainty: the tradeoff between administrative control and commitment" 19 (19): 1007-1028, 1998

28 Pateli, Adamantia G., "Governance Options for Strategic Technology Alliances in Value Webs" 1-10, 2006

29 "Global BioPharmaceutical Royalty Rates and Deal Terms Survey"

30 Li, Ning, "General alliance experience, uncertainty, and marketing alliance governance mode choice" 38 : 141-158, 2010

31 Van de Vrande, Vareska, "External technology sourcing: the effect of uncertainty on governance mode choice" 24 (24): 62-80, 2009

32 Sampson, R. C., "Experience effects and collaborative returns in R&D alliances" 26 (26): 1009-1001, 2005

33 Kale, Prashant, "Building Firm Capabilities Through Learning: The Role Of The Alliance Learning Process In Alliance Capability And Firm-Level Alliance Success" 28 : 981-1000, 2007

34 Dunne, Danielle D., "An empirical study of the impact of firm resources on alliance governance structures" 26 (26): 181-195, 2009

35 Wassmer, Ulrich, "Alliance Portfolios: A Review and Research Agenda" 36 (36): 141-171, 2010

36 McGill, Joseph P., "Alliance Portfolios and Patent Output: The Case of Biotechnology Alliances" 56 (56): 388-400, 2009

37 Schilke, Oliver, "Alliance Management Capability: An Investigation of the Construct and Its Measurement" 36 (36): 1192-1219, 2010